Uncategorized
STAT+: After Eli Lilly granted one man special access to obesity drug, doctors struggle to get answers
Last month, STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an unapproved obesity drug that has demonstrated bariatric-surgery levels of weight loss.
Since then, at least a handful of clinicians have tried to seek the same access for their patients. Two of them haven’t received answers from the drugmaker for weeks; one heard back on Monday, only after STAT reached out to Lilly with questions for this story, that his patient might qualify for access to the drug.
The lack of clarity from Lilly raises new questions about why the company gave extraordinary access to an experimental obesity drug to a single patient. Clinicians are calling for more transparency from Lilly on whether the company plans to expand access, or whether this was a one-time, special circumstance.
Last month, STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an unapproved obesity drug that has demonstrated bariatric-surgery levels of weight loss.
Since then, at least a handful of clinicians have tried to seek the same access for their patients. Two of them haven’t received answers from the drugmaker for weeks; one heard back on Monday, only after STAT reached out to Lilly with questions for this story, that his patient might qualify for access to the drug.
The lack of clarity from Lilly raises new questions about why the company gave extraordinary access to an experimental obesity drug to a single patient. Clinicians are calling for more transparency from Lilly on whether the company plans to expand access, or whether this was a one-time, special circumstance.
Novo Nordisk’s shares fell 6% on Tuesday afternoon after its second quarter earnings report showed a slight miss for the Wegovy pill vs. consensus.
Uncategorized
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
BUNIA, Congo — Ebola has killed more than 1,700 people in eastern Congo in what has become the fastest-growing outbreak of the disease, according to data — spreading faster than health officials can track and with patient zero still unidentified.
As of Tuesday, 3,802 cases had been recorded, with 1,707 deaths, the latest government update showed.
BUNIA, Congo — Ebola has killed more than 1,700 people in eastern Congo in what has become the fastest-growing outbreak of the disease, according to data — spreading faster than health officials can track and with patient zero still unidentified.
As of Tuesday, 3,802 cases had been recorded, with 1,707 deaths, the latest government update showed.
In addition to laying off employees, including a member of its management team, Lisata Therapeutics is also suing Kuva Labs, alleging the company breached a merger agreement.
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
Lisata axes 72% of workforce following failed merger with Kuva
AI Uses MRIs to Generate Brain Aging Maps for Neurodegenerative Disease Research
Pfizer CEO defends $7B bolt-on M&A strategy as peers rush to buy
Beyond the Technology: AI Readiness in Regulated Laboratories
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Fierce Biotech4 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Endpoints News5 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized4 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State